Choose for

All Press Releases All Conference Calls All Shareholder Meetings

Recent Releases

December 02, 2022 17:27:16 ET

SPRUCE BIOSCIENCES, INC. (CIK: 1683553)

EX-10.1 2 sprb-ex10_1.htm EX-10.1 EX-10.1Exhibit 10.1LEASE AGREEMENTTHIS LEASE AGREEMENT (this “Lease”) is made this 1st day of December, 2022, between 611 GATEWAY CENTER LP, a Delaware limited partnership (“Landlord”), and SPRUCE BIOSCIENCES, INC., a Delaware corporation (“Tenant”).Building: 611 Gateway Boulevard, South San Francisco, CaliforniaPremises: That portion of the Building, commonly known as Su More »

December 02, 2022 17:27:16 ET

SPRUCE BIOSCIENCES, INC. (CIK: 1683553)

EX-10.2 3 sprb-ex10_2.htm EX-10.2 EX-10.2Exhibit 10.2LEASE TERMINATION AGREEMENTThis Lease Termination Agreement (this "Agreement") is entered into as of the 28th day of November, 2022 (the "Effective Date"), by and between BP3-SF7 2001 JS OWNER LLC, a Delaware limited liability company ("Landlord"), and SPRUCE BIOSCIENCES, INC., a Delaware corporation ("Tenant").r e c i t a l s A.Landlord (as successor-in-interest More »

December 02, 2022 17:24:39 ET

Associated Capital Group, Inc. (CIK: 1642122)

EX-99.1 2 ex_452605.htm EXHIBIT 99.1 ex_452605.htmExhibit 99.1191 Mason Street Greenwich, Connecticut 06830t: 203.629.9595Associated-Capital-Group.com For Immediate Release:Contact:Douglas R. JamiesonChief Executive Officer(203) 629-9595info@associated-capital-group.comAssociated Capital Group's Board of Directors Approves $3.3 MillionShareholder Designated Charitable Contribution, Bringing Total to $34 millionGreenwich, CT, November 29, 2022  More »

December 02, 2022 17:23:31 ET

Cellectar Biosciences, Inc. (CIK: 1279704)

EX-10.1 3 tm2231728d1_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1PRIVILEGED AND CONFIDENTIALDIRECTOR AND OFFICERINDEMNIFICATION AGREEMENTTHIS INDEMNIFICATION AGREEMENT (this “Agreement”) is entered into as of the ______ day of ___________, 20___, by and between Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), and ____________________ (“Indemnitee”).RECITALSA.The Company is aware that competent and More »

December 02, 2022 17:23:31 ET

Cellectar Biosciences, Inc. (CIK: 1279704)

EX-3.1 2 tm2231728d1_ex3-1.htm EXHIBIT 3.1 Exhibit 3.1AMENDED AND RESTATED BY-LAWSOFCellectar Biosciences, Inc.a Delaware corporationArticle ISTOCKHOLDERSSection 1.1. Annual Meetings. An annual meeting of stockholders to elect directors and transact such other business as may properly be presented to the meeting may be held at such place, within or without the State of Delaware as may be designated by or in the manner provided in the Certific More »